Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 22, 2019
- Accepted August 13, 2019
- Published online December 6, 2019.
Article Versions
- Earlier version (October 31, 2019 - 11:05).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2019 by the American Society of Nephrology
Author Information
- Harish Seethapathy1,
- Sophia Zhao1,
- Donald F. Chute1,
- Leyre Zubiri2,
- Yaa Oppong1,
- Ian Strohbehn1,
- Frank B. Cortazar1,
- David E. Leaf3,
- Meghan J. Mooradian2,
- Alexandra-Chloé Villani4,5,
- Ryan J. Sullivan2,
- Kerry Reynolds2,
- Meghan E. Sise1
- 1Division of Nephrology, Department of Internal Medicine,
- 2Division of Hematology and Oncology, Department of Internal Medicine,
- 4Department of Medicine, Center for Immunology and Inflammatory Diseases, and
- 5Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts; and
- 3Division of Renal Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
- Correspondence:
Dr. Meghan E. Sise, Division of Nephrology, Department of Internal Medicine, Massachusetts General Hospital, 165 Cambridge Street, Suite 302, Boston, MA 02114. Email: msise{at}partners.org
K.R. and M.E.S. contributed equally to this work.
Funding
Amgen
Merck
Statistics from Altmetric.com
Article usage
Cited By...
In this issue
The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
Jump to section
More in this TOC Section
Original Articles
Cited By...
- Gene Expression Profiling in Kidney Transplants with Immune Checkpoint Inhibitor-Associated Adverse Events
- Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data
- Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
- Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study
- Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case-control study
- Nephrotoxicity of the BRAF-kinase inhibitor Vemurafenib is driven by off-target Ferrochelatase inhibition
- Clinically significant estimated glomerular filtration rate decline is common in patients receiving immune checkpoint inhibitors: implications for long-term cancer survivors
- Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma
- Leveraging the Capabilities of the FDAs Sentinel System To Improve Kidney Care
- Use of Checkpoint Inhibitors in a Kidney Transplant Recipient with Metastatic Cancer
- Checkpoint inhibitor-related renal vasculitis and use of rituximab
- Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes
- Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: CON
- Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: PRO
- Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: Commentary
- Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020
- Acute Kidney Injury with Immune Checkpoint Inhibitors: A Push beyond Case Reports
Similar Articles
Related Articles
Keywords
- acute renal failure
- checkpoint inhibitors
- onconephrology
- acute kidney injury
- acute interstitial nephritis
- immune related adverse events
- Humans
- male
- creatinine
- Incidence
- risk factors
- proton pump inhibitors
- Proportional Hazards Models
- renal dialysis
- general hospitals
- Kidney Function Tests
- glomerular filtration rate
- nephrology
- Comorbidity
- chronic renal insufficiency
- nephritis
- Massachusetts